Recommendations for the production and control of group C meningococcal conjugate vaccines, Annex 3, TRS No 926
Addendum 2003
1 January 2004
| Technical document

Overview
At its fifty-second meeting the Expert Committee on Biological Standardization adopted the Recommendations for the production and control of group C meningococcal conjugate vaccines, which were published in its report (1). The Committee agreed with a proposal to draft an addendum on serological assays to evaluate the immune responses to these vaccines and to review the current recommendations in the light of data emerging from the United Kingdom following the introduction of the vaccine, especially data related to the demonstration of immunological memory. The addendum is intended to serve as an Appendix to the already adopted Recommendations.
Full version of the WHO Technical Report Series N° 926
WHO Team
Health Product Policy and Standards (HPS),
Norms and Standards for Biological Products (NSB)
Number of pages
5
Reference numbers
WHO Reference Number: WHO TRS N°926
Copyright
World Health Organization